Vascular Trial Associated Registry Pilot

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 350 participants.

Also called NCT07076082

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 350 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07076082
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07076082. Randomized; no masking; primary purpose treatment. Start 2025-10-15 (actual); primary completion 2027-10-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Vascular Trial Associated Registry Pilot
Acronym
VSTAR-P
Condition
Peripheral Arterial Disease
Intervention (Drug)
Clopidogrel (Plavix) Pharmacogenetic Test Reagents
Lead sponsor
Corewell Health West (class: other)
Collaborator
Henry Ford Hospital (class: other)

Record details

Record id
cardio:ct-nct07076082
Content hash
cc0b6d178c93d061e75869de6ed3aa7cc7736bb7bdb69e29ee61de7fcca0147f